May 9 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
* AS OF MARCH 31, 2023, CO HAD ABOUT $66.2 MILLION IN CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES
* EXPECT CURRENT CASH, CASH EQUIVALENTS, AND MARKETABLE
SECURITIES
TO FUND OPERATIONS INTO THE THIRD QUARTER OF 2024
* QTRLY LOSS PER SHARE $0.29
* Q1 EARNINGS PER SHARE VIEW $-0.29 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7h0Rrs
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))